Literature DB >> 28025387

The challenge of adequate imaging surveillance in primary central nervous system lymphoma.

Uwe Schlegel1, Agnieszka Korfel2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28025387      PMCID： PMC5464301          DOI： 10.1093/neuonc/now273

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

Authors:  Lauren E Abrey; Tracy T Batchelor; Andrés J M Ferreri; Mary Gospodarowicz; Elisa J Pulczynski; Emanuele Zucca; Justine R Smith; Agnieszka Korfel; Carole Soussain; Lisa M DeAngelis; Edward A Neuwelt; Brian Patrick O'Neill; Eckhard Thiel; Tamara Shenkier; Fransesc Graus; Martin van den Bent; John F Seymour; Philip Poortmans; James O Armitage; Franco Cavalli
Journal:  J Clin Oncol       Date:  2005-06-13       Impact factor: 44.544

Review 2.  Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

Authors:  Khê Hoang-Xuan; Eric Bessell; Jacoline Bromberg; Andreas F Hottinger; Matthias Preusser; Roberta Rudà; Uwe Schlegel; Tali Siegal; Carole Soussain; Ufuk Abacioglu; Nathalie Cassoux; Martina Deckert; Clemens M F Dirven; Andrés J M Ferreri; Francesc Graus; Roger Henriksson; Ulrich Herrlinger; Martin Taphoorn; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2015-07       Impact factor: 41.316

3.  Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.

Authors:  Wilhelm Küker; Thomas Nägele; Agnieska Korfel; Stefan Heckl; Eckhard Thiel; Michael Bamberg; Michael Weller; Ulrich Herrlinger
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

4.  Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.

Authors:  Antonio Omuro; Olivier Chinot; Luc Taillandier; Hervé Ghesquieres; Carole Soussain; Vincent Delwail; Thierry Lamy; Rémy Gressin; Sylvain Choquet; Pierre Soubeyran; Aymeri Huchet; Alexandra Benouaich-Amiel; Sophie Lebouvier-Sadot; Emmanuel Gyan; Valérie Touitou; Maryline Barrié; Monica Sierra del Rio; Alberto Gonzalez-Aguilar; Caroline Houillier; Daniel Delgadillo; Lucette Lacomblez; Marie Laure Tanguy; Khê Hoang-Xuan
Journal:  Lancet Haematol       Date:  2015-06-03       Impact factor: 18.959

5.  Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial.

Authors:  Emeline Tabouret; Caroline Houillier; Nadine Martin-Duverneuil; Marie Blonski; Carole Soussain; Herve Ghesquières; Roch Houot; Delphine Larrieu; Pierre Soubeyran; Remy Gressin; Emmanuel Gyan; Olivier Chinot; Luc Taillandier; Sylvain Choquet; Agusti Alentorn; Delphine Leclercq; Antonio Omuro; Marie-Laure Tanguy; Khe Hoang-Xuan
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

6.  Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions.

Authors:  Lars Fischer; Arend Koch; Uwe Schlegel; Hans-Christian Koch; Rüdiger Wenzel; Nicolas Schröder; Eckhard Thiel; Agnieszka Korfel
Journal:  J Neurooncol       Date:  2010-07-03       Impact factor: 4.130

7.  MR imaging features of intracranial primary CNS lymphoma in immune competent patients.

Authors:  Asem Mansour; Monther Qandeel; Hikmat Abdel-Razeq; Hussain Ali Abu Ali
Journal:  Cancer Imaging       Date:  2014-05-07       Impact factor: 3.909

8.  Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

Authors:  Sophie Langner-Lemercier; Caroline Houillier; Carole Soussain; Hervé Ghesquières; Olivier Chinot; Luc Taillandier; Pierre Soubeyran; Thierry Lamy; Franck Morschhauser; Alexandra Benouaich-Amiel; Guido Ahle; Marie-Pierre Moles-Moreau; Cécile Moluçon-Chabrot; Pascal Bourquard; Ghandi Damaj; Fabrice Jardin; Delphine Larrieu; Emmanuel Gyan; Remy Gressin; Arnaud Jaccard; Sylvain Choquet; Annie Brion; Olivier Casasnovas; Philippe Colin; Oumedaly Reman; Adrian Tempescul; Jean-Pierre Marolleau; Michel Fabbro; Florian Naudet; Khê Hoang-Xuan; Roch Houot
Journal:  Neuro Oncol       Date:  2016-03-06       Impact factor: 12.300

Review 9.  Diagnosis and treatment of primary CNS lymphoma.

Authors:  Agnieszka Korfel; Uwe Schlegel
Journal:  Nat Rev Neurol       Date:  2013-05-14       Impact factor: 42.937

10.  Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.

Authors:  Sofiane Maza; Ralph Buchert; Winfried Brenner; Dieter Ludwig Munz; Eckhard Thiel; Agnieszka Korfel; Philipp Kiewe
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991
  10 in total
  1 in total

1.  Cell-Block cytology in diagnosis of primary central nervous system lymphoma: A case report.

Authors:  Kaiyuan Huang; Lei Zhou; Ying Tong
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.